Technical Analysis for ELTX - Elicio Therapeutics, Inc.

Grade Last Price % Change Price Change
C 5.01 -3.56% -0.19
ELTX closed down 3.56 percent on Wednesday, November 20, 2024, on 1.65 times normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.56%
Volume Surge Other -3.56%
Wide Bands Range Expansion -3.56%
Gapped Down Weakness -3.56%
Wide Bands Range Expansion -5.29%
Overbought Stochastic Strength -5.29%
Upper Bollinger Band Walk Strength -8.58%

   Recent Intraday Alerts

Alert Time
2x Volume Pace about 21 hours ago
1.5x Volume Pace about 21 hours ago
3x Volume Pace about 21 hours ago
Down 3% about 21 hours ago
Down 2 % about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Elicio Therapeutics, Inc. Description

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002, to treat or prevent a range of diseases; ELI-003 for cancers involving an ALK mutation; ELI-011 for hematological cancers; ELI-005, a product for the prevention of COVID-19; and ELI-002 7P (AMPLIFY-7P), a vaccine for mutated solid tumors. The company's AMP platform enables to develop differentiated treatment modalities including therapeutic vaccines, adjuvants, and cell therapy AMPlifiers. The company was formerly known as VEDANTRA PHARMACEUTICALS, INC. and changed its name to Elicio Therapeutics Inc. on September 18, 2019. The company was incorporated in 2011 and is headquartered in Boston, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Biology Disease Solid Tumors Treatment Of Cancer Cell Therapy Immunotherapies Vaccines Vaccination Virology Hematological Cancers Anaplastic Lymphoma Kinase

Is ELTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.45
52 Week Low 2.96
Average Volume 20,860
200-Day Moving Average 5.87
50-Day Moving Average 4.79
20-Day Moving Average 4.84
10-Day Moving Average 5.14
Average True Range 0.35
RSI (14) 52.38
ADX 13.49
+DI 20.69
-DI 17.96
Chandelier Exit (Long, 3 ATRs) 4.76
Chandelier Exit (Short, 3 ATRs) 5.10
Upper Bollinger Bands 5.60
Lower Bollinger Band 4.08
Percent B (%b) 0.61
BandWidth 31.37
MACD Line 0.16
MACD Signal Line 0.12
MACD Histogram 0.0375
Fundamentals Value
Market Cap 48.12 Million
Num Shares 9.61 Million
EPS -3.93
Price-to-Earnings (P/E) Ratio -1.27
Price-to-Sales 0.00
Price-to-Book 3.04
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.46
Resistance 3 (R3) 5.47 5.34 5.39
Resistance 2 (R2) 5.34 5.22 5.33 5.36
Resistance 1 (R1) 5.17 5.15 5.11 5.16 5.33
Pivot Point 5.04 5.04 5.00 5.03 5.04
Support 1 (S1) 4.87 4.92 4.81 4.86 4.69
Support 2 (S2) 4.74 4.85 4.73 4.66
Support 3 (S3) 4.57 4.74 4.64
Support 4 (S4) 4.56